A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells

Journal of Immunology

Volumn 156, Issue 6, 1996, Pages 2124-2132

  Ruzek, Melanie C ^a   Billadeau, Daniel ^b   Mathur, Ambika ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL CONTACT; CONTACT INHIBITION; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SPLEEN CELL;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CELL COMMUNICATION; COCULTURE TECHNIQUES; DOWN-REGULATION; FEMALE; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMACYTOMA; RECEPTORS, IGE; SPLEEN; TUMOR CELLS, CULTURED;

EID: 0029870090     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mathur, A., S. Maekawa, Z. Ovary, and R. G Lynch. 1986 Increased Tε cells in BALB/c mice wilh an IgE-secreting hybridoma. Mol. Immunol 23:1193.
2. Ruzek, M. C., and A Mathur. 1995. Specific decrease of Th1-like activity in mice with plasma cell tumors. Int. Immunol. 7.1029.
3. Ruzek, M. C., and A. Mathur. 1995. Plasma cell tumors induce loss of CD23 mRNA expression in vivo in murine splenic B cells. Eur. J. Immunol 25:2228.
4. Conrad, D. H. 1990. FcεRII/CD23: the low affinity receptor for IgE. Annu Rev. Immunol. 8:623.
5. Waldschmidt, T. J., K. Snapp, T. Foy, L Tygrett, and C Carpenter. 1992. B-cell subsets defined by the FcεR. Ann. NY Acad Sci. 651.84.
6. Rabin, E , C. Ying-Zi, and H. H. Wortis. 1992. Loss of CD23 is a consequence of B-cell activation, implication for the analysis of B-cell lineages. Ann. NY Acad. Sci 651:130.
7. Waldschmidt, T. J , D H Conrad, and R G. Lynch 1988. The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor. J Immunol. 140:2148.
8. Lee, W T., M. Rao, and D. H. Conrad. 1987 The murine lymphocyte receptor for IgE IV. The mechanism of ligand-specific receptor upregulation on B cells J. Immunol 139.1191.
9. Hudak, S A., S O. Gollnick, D H. Conrad, and M R. Kehry. 1987. Murine B-cell stimulatory factor 1 (interleukin 4) increases expression of the Fc receptor for IgE on mouse B cells. Proc. Natl. Acad Sci USA 84:4606.
10. Conrad, D. H , T. J. Waldschmidt, W T. Lee, M. Rao, A. D. Keegan, R. J. Noelle, R. G Lynch, and M. R. Kehry. 1987. Effect of B cell stimulatory factor-1 (interleukin 4) on Fcε and Fcγ receptor expression on murine B lymphocytes and B cell lines. J. Immunol. 139:2290.
11. Berg, D. J., and R. G Lynch. 1991. Immune dysfunction in mice with plasmacytomas. 1 Evidence that transforming growth factor-β contributes to the altered expression of activation receptors on host B lymphocytes. J. Immunol. 146:2865
12. Bottcher, I., M. Ulrich, N. Hirayama, and Z. Ovary. 1980. Production of monoclonal mouse IgE antibodies with DNP-specificity by hybrid cell lines. Int. Arch. Allergy Appl. Immunol. 61:2865.
13. Barer, M. R., and H. O. Lyon. 1987 The impact of different fixation procedures on staining macromolecules in a microtiter system. Histochem. J. 19 671.
14. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993 Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
15. Kim, J. M., C. I. Brannan, N. G. Copeland, N. A Jenkins, T A. Khan, and K. W. Moore 1992. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148:3618.
16. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980.
17. Billadeau, D., G. Ahmann, P. Greipp, and B. Van Ness. 1993. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp Med. 178:1023.
18. Corsaro, C. M., and M. L. Pearson. 1981. Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells Somat. Cell Genet. 7:603.
19. Go, N. F., B. E. Castle, R. Barrett, R. Kastelein, W. Dang, T. R Mosmann, K. W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
20. Conrad, D. H., A. D. Keegan, K. R. Kalli, R Van Dusen, M. Rao, and A D. Levine. 1988. Superinduction of low affinity IgE receptors on murine B lymphocytes by lipopolysaccharide and EL-4. J. Immunol. 141 1091.
21. Bost, K. L., S. C. Bieligk, and B. M Jaffe. 1995. Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. J. Immunol 154:718.
22. Gorelik, L , A. Prokhorova, and M. B. Mokyr. 1994. Low-dose melphalan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor. Cancer Immunol. Immunother. 39:117.
23. Gotlieb, W. H., J. S Abrams, J. M. Watson, T J. Velu, J. S. Berek, and O. Martinez-Maza. 1992. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other ultra-abdominal cancers. Cytokine 4:385.
24. Ohmen, J. D., J. M. Hanifin, B. J. Nickoloff, T H Rea, R. Wyzykowski, J. Kim, D. Jullien, T. McHugh, A. S. Nassif, S. C. Chan, and R. L. Modlin. 1995. Overexpression of IL-10 in atopic dermatitis, contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1956.
25. Florquin, S , Z. Amraoui, D. Abramowicz, and M. Goldman. 1994. Systemic release and protective role of IL-10 in stapylococcal enterotoxin B-induced shock in mice. J. Immunol. 153:2618
26. Street, N. E., and T. R. Mosmann. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5:171.
27. Jacobson, D. R., and S. Zolla-Pazner. 1986. Immunosuppression and infection in multiple myeloma Semin. Oncol. 13:282.
28. Mond, J. J., E. Seghal, J Kung, and F. D. Finkelman. 1981. Increased expression of I-region associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin. J. Immunol. 127.881.
29. Roehm, N. W , H. J. Leibson, A. Zlotnik, J. Kappler, P. Marrack, and J. C Gambier. 1984. Interleukin-induced increase in Ia expression by normal mouse B cells. J. Exp. Med. 160:679.
30. Ohmen, J. D., J. M. Hanifin, B. J. Nickoloff, T. H. Rea, R. Wyzykowski, J. Kim, D. Jullien, T. McHugh, A. S. Nassif, S. C. Chan, and R. L. Modlin. 1995. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1956.
31. Llorente, L., W. Zou, Y Levy, Y. Richaud-Patin, J. Wijdenes, J. Alcocer-Varela, B. Morel-Fourrier, J.-C. Brouet, D. Alarcon-Segovia, P. Galanaud, and D. Emilie 1995 Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J. Exp. Med. 181:839
32. Pechanha, L. M. T., C. M. Snapper, A. Lees, H. Yamaguchi, and J. J. Mond 1993. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J. Immunol. 150:3215.
33. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human B cell activation, proliferation and differentiation. J. Immunol. 154:4341.
34. Chen, Y., L. T. Hwang, and P. Heller. 1992. Immunosuppression in plasmacytoma induction of suppressor cells. Clin. Exp Immunol. 47:191
35. Varesio, L., M. Giovarelli, S. Landolfo, and G. Forni. 1979. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res 39:4983.
36. Eris, J. M., A. Basten, R Brink, K. Doherty, M. R. Kehry, and P. D. Hodgkin. 1994. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc. Natl. Acad. Sci. USA 91:4392.
37. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, R. Hsu, D.-H. Kastelein, K. W. Moore, and J. Banchereau 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci USA 89:1890